In a world chasing passive giants, Australian small caps shine with active alpha, sector diversity, and next-gen growth ...

Their first product, Illuccix, is a diagnostic imaging agent that allows PET scanners to light up the prostate cancer cells ...

These payments to super come from your pre-tax income and include Superannuation Guarantee payments. You could contribute up ...

Australian bonds experienced a resurgence, posting their best financial year since 2018/19. Some managers returned close to ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Explore U.S. economic trends: growth uncertainty and rising inflation risks.

In a market full of flashy tech and speculative growth stories, here's a refreshingly grounded stock to watch.

The RBA’s proposed surcharge ban and fee caps may reshape payments, but Visa and Mastercard are already positioned for the ...

ARK strives to invest at the pace of innovation. The ARK Global Disruptive Innovation Fund aims to achieve a target average ...

Over the last 12 months to 30 June 2025, Bloomberg data revealed that CBA alone accounted for 33% of the S&P/ASX 200’s total ...

Greg Sharenow, managing director and portfolio manager, charts the continued resilience of commodities and their low ...

Forget AI stocks. It was the old-world store of value and the new-age digital gold that stole the show in FY25.